quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:12:38·6d
SECFiling
Zai Lab Limited logo

SEC Form PRE 14A filed by Zai Lab Limited

ZLAB· Zai Lab Limited
Health Care
Original source

Companies

  • ZLAB
    Zai Lab Limited
    Health Care

Recent analyst ratings

  • Aug 25UpdateJefferies$52.00
  • Mar 7UpdateScotiabank$55.00
  • Mar 3UpdateBofA Securities$36.10
  • Dec 14UpdateMorgan Stanley$47.50
  • Aug 10UpdateCantor Fitzgerald$70.00
  • Mar 2UpdateSVB Leerink$102.00

Related

  • PR1d
    Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026
  • PR6d
    Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer with Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas
  • PR8d
    Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
  • INSIDER15d
    SEC Form 4 filed by Smiley Joshua L
  • INSIDER15d
    SEC Form 4 filed by Edmondson Frazor Titus Iii
  • INSIDER15d
    SEC Form 4 filed by Du Ying
  • INSIDER15d
    SEC Form 4 filed by Chen Yajing
  • INSIDER15d
    SEC Form 4 filed by Amado Rafael
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022